AUKELSO Trademark

Trademark Overview

On Monday, May 6, 2024, a trademark application was filed for AUKELSO with the United States Patent and Trademark Office. The USPTO has given the AUKELSO trademark a serial number of 98535453. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 3, 2024. This trademark is owned by Biocon Biologics Limited. The AUKELSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, medical and biological preparations for treatment of osteoporosis in postmenopausal women; pharmaceutical, medical and biological preparations for increasing bone mass in men with osteoporosis; pharmaceutical, medical and biological preparations for treatment of glucocorticoid-induced osteoporosis; pharmaceutical, medical and biological preparations for treatment of bone loss in men receiving androgen deprivation therapy for prostate cancer; pharmaceutical, medical and biological preparations for treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer
aukelso

General Information

Serial Number98535453
Word MarkAUKELSO
Filing DateMonday, May 6, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical, medical and biological preparations for treatment of osteoporosis in postmenopausal women; pharmaceutical, medical and biological preparations for increasing bone mass in men with osteoporosis; pharmaceutical, medical and biological preparations for treatment of glucocorticoid-induced osteoporosis; pharmaceutical, medical and biological preparations for treatment of bone loss in men receiving androgen deprivation therapy for prostate cancer; pharmaceutical, medical and biological preparations for treatment of bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiocon Biologics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBengaluru, Karnataka 560100
IN

Trademark Events

Event DateEvent Description
Monday, May 6, 2024NEW APPLICATION ENTERED
Tuesday, May 7, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 7, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 31, 2024ASSIGNED TO EXAMINER
Saturday, August 31, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 31, 2024NON-FINAL ACTION E-MAILED

Related Keywords

aukelso pharmaceutical preparations biological medical treatment bone osteoporosis receiving cancer loss